Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
Combination of radiotherapy and a drug named S247 as a cure for cancer

Combination of radiotherapy and a drug named S247 as a cure for cancer

EphA2 represents a promising treatment target for glioblastoma multiforme

EphA2 represents a promising treatment target for glioblastoma multiforme

Researchers at Johns Hopkins have identified three new genetic mutations in brain tumors

Researchers at Johns Hopkins have identified three new genetic mutations in brain tumors

Mutations in receptor tyrosine kinases provide potential for highly-targeted cancer therapies

Mutations in receptor tyrosine kinases provide potential for highly-targeted cancer therapies

Combined gene therapy eliminates glioblastoma multiforme in lab studies

Combined gene therapy eliminates glioblastoma multiforme in lab studies

Asthma may be linked to a decreased risk of brain cancer

Asthma may be linked to a decreased risk of brain cancer

Having asthma, hay fever or another allergic condition may reduce the risk of developing Glioblastoma multiforme

Having asthma, hay fever or another allergic condition may reduce the risk of developing Glioblastoma multiforme

Study examines biomarkers for response to erlotinib in glioma

Study examines biomarkers for response to erlotinib in glioma

Chemotherapy for brain tumors is boosted after vaccine targets resistance-related TRP-2 antigen

Chemotherapy for brain tumors is boosted after vaccine targets resistance-related TRP-2 antigen

European approval of Temodal (temozolomide) capsules for treatment of glioblastoma multiforme

European approval of Temodal (temozolomide) capsules for treatment of glioblastoma multiforme

Lorus Therapeutics receives patent allowance to protect novel anticancer drug

Lorus Therapeutics receives patent allowance to protect novel anticancer drug

Virus that targets and kills glioblastoma

Virus that targets and kills glioblastoma

Research offers new molecular approaches to therapies for the most deadly cancers

Research offers new molecular approaches to therapies for the most deadly cancers

Promising new molecular targets and treatment approaches for some of the most malignant brain tumors

Promising new molecular targets and treatment approaches for some of the most malignant brain tumors

Isotopes for society

Isotopes for society

Approval for Temodar (temozolomide) capsules for newly diagnosed glioblastoma multiforme

Approval for Temodar (temozolomide) capsules for newly diagnosed glioblastoma multiforme

New chemotherapy gives hope to brain tumour patients

New chemotherapy gives hope to brain tumour patients

Trial shows which brain cancer patients benefit from temozolomide

Trial shows which brain cancer patients benefit from temozolomide

Researchers are making inroads to understanding what makes brain tumors so hard to treat

Researchers are making inroads to understanding what makes brain tumors so hard to treat

BNCT treatment has had an excellent response in a patient with head and neck cancer

BNCT treatment has had an excellent response in a patient with head and neck cancer